DK1140191T3 - Kombinationer af ileumgaldesyretransportinhibitorer og nicotinsyrederivater til cardiovaskulære indikationer - Google Patents
Kombinationer af ileumgaldesyretransportinhibitorer og nicotinsyrederivater til cardiovaskulære indikationerInfo
- Publication number
- DK1140191T3 DK1140191T3 DK99967141T DK99967141T DK1140191T3 DK 1140191 T3 DK1140191 T3 DK 1140191T3 DK 99967141 T DK99967141 T DK 99967141T DK 99967141 T DK99967141 T DK 99967141T DK 1140191 T3 DK1140191 T3 DK 1140191T3
- Authority
- DK
- Denmark
- Prior art keywords
- combinations
- transport inhibitors
- cardiovascular indications
- acid derivatives
- nicotinic acid
- Prior art date
Links
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 title 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 title 1
- 239000003613 bile acid Substances 0.000 title 1
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
- 210000003405 ileum Anatomy 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11395598P | 1998-12-23 | 1998-12-23 | |
| US14255099P | 1999-07-07 | 1999-07-07 | |
| PCT/US1999/027950 WO2000038729A1 (en) | 1998-12-23 | 1999-12-17 | Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1140191T3 true DK1140191T3 (da) | 2003-02-24 |
Family
ID=26811675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99967141T DK1140191T3 (da) | 1998-12-23 | 1999-12-17 | Kombinationer af ileumgaldesyretransportinhibitorer og nicotinsyrederivater til cardiovaskulære indikationer |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20030125316A1 (da) |
| EP (1) | EP1140191B1 (da) |
| JP (1) | JP2002533415A (da) |
| KR (1) | KR20010102963A (da) |
| CN (1) | CN1338946A (da) |
| AR (1) | AR037806A1 (da) |
| AT (1) | ATE226448T1 (da) |
| AU (1) | AU776952B2 (da) |
| BR (1) | BR9916567A (da) |
| CA (1) | CA2356664A1 (da) |
| CZ (1) | CZ20012343A3 (da) |
| DE (1) | DE69903661T2 (da) |
| DK (1) | DK1140191T3 (da) |
| EA (1) | EA005030B1 (da) |
| ES (1) | ES2188285T3 (da) |
| HK (1) | HK1044472A1 (da) |
| HU (1) | HUP0104593A3 (da) |
| IL (1) | IL143938A0 (da) |
| MX (1) | MXPA01006467A (da) |
| MY (1) | MY121399A (da) |
| NO (1) | NO20013160L (da) |
| NZ (1) | NZ512533A (da) |
| PL (1) | PL348581A1 (da) |
| PT (1) | PT1140191E (da) |
| WO (1) | WO2000038729A1 (da) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000772D0 (sv) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | Chemical compounds |
| WO2001068096A2 (en) * | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| GB0121621D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| GB0121622D0 (en) | 2001-09-07 | 2001-10-31 | Astrazeneca Ab | Chemical compounds |
| CN1582151A (zh) | 2001-09-08 | 2005-02-16 | 阿斯特拉曾尼卡有限公司 | 用于治疗高脂血症、具有回肠胆汁酸转运(ibat)抑制活性的苯并硫氮杂䓬和苯并硫杂二氮杂䓬衍生物 |
| GB0209467D0 (en) | 2002-04-25 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| GB0304194D0 (en) | 2003-02-25 | 2003-03-26 | Astrazeneca Ab | Chemical compounds |
| GB0307918D0 (en) | 2003-04-05 | 2003-05-14 | Astrazeneca Ab | Therapeutic use |
| CA2815698C (en) * | 2010-11-08 | 2019-04-30 | Albireo Ab | A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| SI2637668T1 (sl) | 2010-11-08 | 2016-11-30 | Albiero Ab | IBAT inhibitorji za zdravljenje jetrnih bolezni |
| JP2012171911A (ja) | 2011-02-22 | 2012-09-10 | Kao Corp | Ｐｐａｒ活性化剤 |
| CA2876540C (en) * | 2012-06-15 | 2022-11-29 | Conaris Research Institute Ag | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| KR20220082931A (ko) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
| TWI691331B (zh) | 2014-09-26 | 2020-04-21 | 日商興和股份有限公司 | 脂質異常症治療劑 |
| EP3012252A1 (en) | 2014-10-24 | 2016-04-27 | Ferring BV | Crystal modifications of elobixibat |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| JP6954927B2 (ja) | 2016-02-09 | 2021-10-27 | アルビレオ・アクチボラグ | 経口コレスチラミン製剤及びその使用 |
| CN108601744B (zh) | 2016-02-09 | 2022-01-04 | 阿尔比里奥公司 | 口服考来烯胺制剂及其用途 |
| CN110996915B (zh) | 2017-08-09 | 2023-10-03 | 阿尔比里奥公司 | 考来烯胺丸粒、口服考来烯胺制剂及其用途 |
| CN111032019B (zh) | 2017-08-09 | 2022-07-05 | 阿尔比里奥公司 | 考来烯胺颗粒、口服考来烯胺制剂及其用途 |
| TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| WO2019245449A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| AU2020218908A1 (en) | 2019-02-06 | 2021-08-26 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| WO2020161216A1 (en) | 2019-02-06 | 2020-08-13 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| CR20220315A (es) | 2019-12-04 | 2022-10-26 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del ácido biliar |
| AR120683A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como ácido biliar |
| WO2021110883A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202134221A (zh) | 2019-12-04 | 2021-09-16 | 瑞典商艾爾比瑞歐公司 | 苯并噻二氮呯化合物及其作為膽酸調節劑之用途 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| WO2021110887A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| AR120676A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como ácido biliar |
| CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| JP2023504644A (ja) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| JP2023537285A (ja) | 2020-08-03 | 2023-08-31 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
| EP4255565A1 (en) | 2020-12-04 | 2023-10-11 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| WO2023237728A1 (en) | 2022-06-09 | 2023-12-14 | Albireo Ab | Treating hepatitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19916108C1 (de) * | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
-
1999
- 1999-12-17 PL PL99348581A patent/PL348581A1/xx not_active Application Discontinuation
- 1999-12-17 NZ NZ512533A patent/NZ512533A/xx unknown
- 1999-12-17 EA EA200100703A patent/EA005030B1/ru not_active IP Right Cessation
- 1999-12-17 KR KR1020017008067A patent/KR20010102963A/ko not_active Application Discontinuation
- 1999-12-17 WO PCT/US1999/027950 patent/WO2000038729A1/en not_active Application Discontinuation
- 1999-12-17 AU AU23481/00A patent/AU776952B2/en not_active Ceased
- 1999-12-17 BR BR9916567-8A patent/BR9916567A/pt not_active IP Right Cessation
- 1999-12-17 HU HU0104593A patent/HUP0104593A3/hu unknown
- 1999-12-17 CN CN99816327A patent/CN1338946A/zh active Pending
- 1999-12-17 CA CA002356664A patent/CA2356664A1/en not_active Abandoned
- 1999-12-17 AT AT99967141T patent/ATE226448T1/de not_active IP Right Cessation
- 1999-12-17 ES ES99967141T patent/ES2188285T3/es not_active Expired - Lifetime
- 1999-12-17 CZ CZ20012343A patent/CZ20012343A3/cs unknown
- 1999-12-17 MX MXPA01006467A patent/MXPA01006467A/es not_active Application Discontinuation
- 1999-12-17 EP EP99967141A patent/EP1140191B1/en not_active Revoked
- 1999-12-17 DK DK99967141T patent/DK1140191T3/da active
- 1999-12-17 JP JP2000590680A patent/JP2002533415A/ja active Pending
- 1999-12-17 PT PT99967141T patent/PT1140191E/pt unknown
- 1999-12-17 DE DE69903661T patent/DE69903661T2/de not_active Expired - Fee Related
- 1999-12-17 IL IL14393899A patent/IL143938A0/xx unknown
- 1999-12-22 MY MYPI99005678A patent/MY121399A/en unknown
- 1999-12-23 AR ARP990106755A patent/AR037806A1/es unknown
-
2001
- 2001-06-22 NO NO20013160A patent/NO20013160L/no not_active Application Discontinuation
-
2002
- 2002-08-21 HK HK02106126.2A patent/HK1044472A1/zh unknown
- 2002-09-18 US US10/245,507 patent/US20030125316A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PL348581A1 (en) | 2002-06-03 |
| EP1140191A1 (en) | 2001-10-10 |
| WO2000038729A1 (en) | 2000-07-06 |
| AR037806A1 (es) | 2004-12-09 |
| HK1044472A1 (zh) | 2002-10-25 |
| DE69903661T2 (de) | 2003-07-03 |
| EA200100703A1 (ru) | 2001-12-24 |
| KR20010102963A (ko) | 2001-11-17 |
| JP2002533415A (ja) | 2002-10-08 |
| CN1338946A (zh) | 2002-03-06 |
| HUP0104593A3 (en) | 2004-10-28 |
| IL143938A0 (en) | 2002-04-21 |
| MY121399A (en) | 2006-01-28 |
| BR9916567A (pt) | 2001-12-11 |
| US20030125316A1 (en) | 2003-07-03 |
| MXPA01006467A (es) | 2004-03-10 |
| ATE226448T1 (de) | 2002-11-15 |
| DE69903661D1 (de) | 2002-11-28 |
| CA2356664A1 (en) | 2000-07-06 |
| AU2348100A (en) | 2000-07-31 |
| EP1140191B1 (en) | 2002-10-23 |
| EA005030B1 (ru) | 2004-10-28 |
| NO20013160L (no) | 2001-08-21 |
| PT1140191E (pt) | 2003-01-31 |
| HUP0104593A2 (hu) | 2002-03-28 |
| NZ512533A (en) | 2004-02-27 |
| NO20013160D0 (no) | 2001-06-22 |
| ES2188285T3 (es) | 2003-06-16 |
| AU776952B2 (en) | 2004-09-30 |
| CZ20012343A3 (cs) | 2001-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1140191T3 (da) | Kombinationer af ileumgaldesyretransportinhibitorer og nicotinsyrederivater til cardiovaskulære indikationer | |
| DK1140189T3 (da) | Kombinationer af ileal galdesyre-transportinhibitorer og fibrinsyrederivater til cardiovaskulære indikationer | |
| DK1140190T3 (da) | Kombinationer af ileumgaldesyretransport-inhibitorer og galdesyre-sekvestreringsmidler til cardiovaskulære indikatorer | |
| DK1140187T3 (da) | Kombinationer af en IBAT-inhibitor og en MTP-inhibitor til cardiovaskulære indikationer | |
| DK1210503T3 (da) | Apparat og fremgangsmåde til forankring af en ekspanderbar rörledning | |
| NO20014823L (no) | Heterocyklus-holdige bifenyl-aP2-inhibitorer og metode | |
| DK1064094T3 (da) | Apparat til coating af monolitiske understøtninger og fremgangsmåde herfor | |
| DK1177694T3 (da) | Fremgangsmåde og system til levering af gps- | |
| DK1212732T3 (da) | Fremgangsmåder og apparat til gennemförelse af elektroniske transaktioner | |
| NO20012103L (no) | Fremgangsmåte for transportering og installering av et ekspanderbart stålrör | |
| NO20015783L (no) | Sammensetning og fremgangsmåte for hemming av metallkorrosjon | |
| DK1017925T3 (da) | Fremgangsmåde og forbindelse til at inhibere tilstopning af ledninger med gashydrater | |
| DK1071745T3 (da) | Fremgangsmåde til syntetisering af COX-2-inhibitorer | |
| NO982176L (no) | Korrosjonsinhiberte organiske syresammensetninger og fremgangsmÕter for anvendelse av disse | |
| DK0967975T3 (da) | Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre | |
| DK1058769T3 (da) | Apparat til færdiggörelse af en underjordisk brönd og fremgangsmåde til anvendelse af samme | |
| IS1758B2 (is) | Aðferð til nákvæms og sjálfvirks þyngdarsamvals úr raðflæði stykkja | |
| DK1091938T3 (da) | Antihistamin piperidinderivativer og mellemprodukter til fremstilling af disse | |
| DK1036319T3 (da) | Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf | |
| NO20012293D0 (no) | Utvidbar stent og fremgangsmåte for fremstilling | |
| DK1070444T3 (da) | Fremgangsmåde og anordning til fremstilling af tyndtlagsstrukturer | |
| IS5151A (is) | Aðferð og búnaður til sjálfvirkrar stöflunar á vörubretti | |
| DK0790317T3 (da) | Fremgangsmåde baseret på inhibering af phosphataser til detektering og bestemmelse af diarrhoefremkaldende skaldyrsforgiftning | |
| DK0948685T3 (da) | Træstykke og fremgangsmåde til stötte af det |